Maurus de la Rosa
- Immunology top 2%
- Molecular Biology
- Oncology top 10%
- Genetics top 5%
- Hematology top 5%
- Co-authors
- Alexander ScheffoldSascha RutzJochen HuehnJoachim LehmannAlf HamannBirgit M. ReipertMonika C. Brunner‐WeinzierlVeit Krenn
- Topics
- CAR-T cell therapy research (9 papers)Virus-based gene therapy research (8 papers)Immune Cell Function and Interaction (8 papers)
- Cited by
- ImmunologyHematologyOncology
- Partner nations
- United StatesGermanyAustria
In The Last Decade
Maurus de la Rosa
18 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Immunology 1.5k
- Molecular Biology 415
- Oncology 410
- Genetics 388
- Hematology 172
Countries citing papers authored by Maurus de la Rosa
This map shows the geographic impact of Maurus de la Rosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maurus de la Rosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maurus de la Rosa more than expected).
Fields of papers citing papers by Maurus de la Rosa
This network shows the impact of papers produced by Maurus de la Rosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maurus de la Rosa. The network helps show where Maurus de la Rosa may publish in the future.
Co-authorship network of co-authors of Maurus de la Rosa
This figure shows the co-authorship network connecting the top 25 collaborators of Maurus de la Rosa. A scholar is included among the top collaborators of Maurus de la Rosa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maurus de la Rosa. Maurus de la Rosa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 15 | |
| 3 | 2 | |
| 4 | 3 | |
| 5 | 138 | |
| 6 | 12 | |
| 7 | 10 | |
| 8 | 137 | |
| 9 | 25 | |
| 10 | 0 | |
| 11 | 136 | |
| 12 | 23 | |
| 13 | 2 | |
| 14 | 65 | |
| 15 | 223 | |
| 16 | 92 | |
| 17 | 415 | |
| 18 | Developmental Stage, Phenotype, and Migration Distinguish Naive- and Effector/Memory-like CD4+ Regulatory T Cellsbreakdown → | 520 |
| 19 | 398 |
About Maurus de la Rosa
Maurus de la Rosa is a scholar working on Immunology, Oncology and Genetics, having authored 19 papers that have together received 2.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (9 papers), Virus-based gene therapy research (8 papers) and Immune Cell Function and Interaction (8 papers). The work is most often cited by research in Immunology (1.5k citations), Hematology (172 citations) and Oncology (410 citations). Maurus de la Rosa has collaborated with scholars based in United States, Germany and Austria. Frequent co-authors include Alexander Scheffold, Sascha Rutz, Jochen Huehn, Joachim Lehmann, Alf Hamann, Birgit M. Reipert, Monika C. Brunner‐Weinzierl, Veit Krenn, Friedrich Scheiflinger and Kevin Thurley. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.